Table 13 Follow-up of patients undergoing endovascular treatment [example (%)].
Items | Type A IMH group (n = 15) | Type B IMH group (n = 60) |
|---|---|---|
Complications | 3 (20.0) | 6 (10.0) |
Endoleak | 3 (20.0)** | 6 (10.0)** |
Secondary intervention | 0 (0) | 0 (0) |
Disease-related death | 0 (0) | 0 (0) |
All cause death | 0 (0) | 0 (0) |